Teza Capital Management LLC Sells 2,479 Shares of CME Group Inc. (NASDAQ:CME)

Teza Capital Management LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 70.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,040 shares of the financial services provider's stock after selling 2,479 shares during the period. Teza Capital Management LLC's holdings in CME Group were worth $242,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. New Age Alpha Advisors LLC increased its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares in the last quarter. Avidian Wealth Enterprises LLC grew its holdings in CME Group by 2.6% during the 4th quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock worth $411,000 after acquiring an additional 45 shares during the last quarter. TFC Financial Management Inc. grew its holdings in CME Group by 8.4% during the 4th quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock worth $137,000 after acquiring an additional 46 shares during the last quarter. Waldron Private Wealth LLC increased its position in CME Group by 2.0% in the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after acquiring an additional 47 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its stake in shares of CME Group by 12.1% in the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock worth $101,000 after acquiring an additional 47 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

CME Group Price Performance

NASDAQ CME opened at $277.87 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a market cap of $100.13 billion, a price-to-earnings ratio of 28.74, a PEG ratio of 6.76 and a beta of 0.45. The business has a 50 day simple moving average of $266.65 and a 200 day simple moving average of $247.92. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the prior year, the company earned $2.50 earnings per share. The business's quarterly revenue was up 10.4% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is 50.30%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Piper Sandler boosted their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. JPMorgan Chase & Co. dropped their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Finally, UBS Group increased their target price on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Three analysts have rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $256.80.

Insider Activity

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the sale, the director now directly owns 3,108 shares in the company, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the sale, the director now directly owns 5,400 shares in the company, valued at $1,471,824. This trade represents a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 27,494 shares of company stock worth $7,281,618 over the last three months. Corporate insiders own 0.30% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.